quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:38:18·24d
SECFiling
Ensysce Biosciences Inc. logo

SEC Form 10-K filed by Ensysce Biosciences Inc.

ENSC· Ensysce Biosciences Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • ENSC
    Ensysce Biosciences Inc.
    Health Care

Recent analyst ratings

  • Nov 30UpdateLake Street$4.00

Related

  • NEWS7d
    Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
  • SEC8d
    SEC Form EFFECT filed by Ensysce Biosciences Inc.
  • SEC15d
    SEC Form S-3 filed by Ensysce Biosciences Inc.
  • SEC16d
    Ensysce Biosciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
  • NEWS16d
    Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
  • SEC20d
    SEC Form 8-K filed by Ensysce Biosciences Inc.
  • SEC24d
    Ensysce Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • NEWS24d
    Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022